NON-SMALL CELL CARCINOMA
Clinical trials for NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Two-Drug attack on tough lung cancers
Disease control Recruiting nowThis early-stage study is testing whether combining an experimental drug called binimetinib with an existing immunotherapy (pembrolizumab) is safe and helpful for people with advanced non-small cell lung cancer. Researchers will first find the safest dose of the combination, then…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Radiation 'Hammer' aims to boost cancer drug power
Disease control Recruiting nowThis study is testing if adding a precise, high-dose radiation treatment to liver tumors helps standard immunotherapy drugs work better for people with advanced lung cancer that has spread to the liver. It will compare the standard drug treatment alone to the drug treatment plus …
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New hope for Tough-to-Treat lung cancer: major trial tests promising drug
Disease control Recruiting nowThis study is testing if a new drug called PF-08046054 works better than the standard chemotherapy drug docetaxel for people with advanced non-small cell lung cancer. It is for adults whose cancer has spread, cannot be removed by surgery, and has gotten worse despite trying other…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Can a phone coach get lung cancer survivors moving?
Symptom relief Recruiting nowThis study is testing whether a 12-week phone and app-based exercise coaching program helps people walk more and improve their quality of life after surgery for non-small cell lung cancer. Researchers will enroll 90 patients who had surgery 1 to 12 months ago and randomly assign …
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Mar 25, 2026 14:07 UTC